1. Home
  2. FTCI vs ANIX Comparison

FTCI vs ANIX Comparison

Compare FTCI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$2.36

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.84

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
ANIX
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
114.0M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
FTCI
ANIX
Price
$2.36
$2.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$10.80
$8.67
AVG Volume (30 Days)
273.5K
269.1K
Earning Date
05-01-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.82
EPS
N/A
N/A
Revenue
$99,687,000.00
$210,000.00
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
N/A
52 Week Low
$1.99
$2.32
52 Week High
$12.75
$5.46

Technical Indicators

Market Signals
Indicator
FTCI
ANIX
Relative Strength Index (RSI) 42.60 30.14
Support Level $1.99 $2.73
Resistance Level $2.90 $3.09
Average True Range (ATR) 0.22 0.23
MACD 0.08 -0.08
Stochastic Oscillator 42.08 4.62

Price Performance

Historical Comparison
FTCI
ANIX

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: